Physicians should find a way to balance their responsibility to care for individual patients with their desire to serve as public policy advocates so that they do not become overwhelmed in handling both roles.
Physicians should find a way to balance their responsibility to care for individual patients with their desire to serve as public policy advocates so that they do not become overwhelmed in handling both roles.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
A case that explores the impact of financial incentives from insurance companies on the patient-physician relationship and whether or not they should be disclosed to a patient.